LU93156I2
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Abstract
This record has no abstract on file.
Term
9.8 yearsto projected expiry
Projected expiry 20 July 2036, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
69 members in 24 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 33580701 | United States of America | P | |
| 33580701 | United States of America | P | |
| 0238602 | United States of America | W | |
| 0238602 | United States of America | W | |
| US20010335807P | – | – | – |
| WO2002US38602 | – | – | – |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| CA2468748A1 | Canada | A1 | |
| CA2655959A1 | Canada | A1 | |
| WO03049744A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002348272A1 | Australia | A1 | |
| US2003139381A1 | United States of America | A1 | |
| WO03049744B1 | World Intellectual Property Organization (WIPO) | B1 | |
| EP1453521A1 | European Patent Office (EPO) | A1 | |
| BR0214716A | Brazil | A | |
| CN1599614A | China | A | |
| MXPA04005445A | Mexico | A | |
| BG108736A | Bulgaria | A | |
| HU0402651A2 | Hungary | A2 | |
| HUP0402651A2 | Hungary | A2 | |
| PL370135A1 | Poland | A1 | |
| RU2004121155A | Russian Federation | A | |
| JP2005516913A | Japan | A | |
| ZA200404249B | South Africa | B | |
| IL162182A0 | Israel | A0 | |
| IL162182D0 | Israel | D0 | |
| HK1076716A | Hong Kong, China | A | |
| HK1076716A1 | Hong Kong, China | A1 | |
| NZ533242A | New Zealand | A | |
| US7320969B2 | United States of America | B2 | |
| US2008064670A1 | United States of America | A1 | |
| US2008132473A1 | United States of America | A1 | |
| AU2002348272B2 | Australia | B2 | |
| NZ555299A | New Zealand | A | |
| AU2008237614A1 | Australia | A1 | |
| HU0402651A3 | Hungary | A3 | |
| HUP0402651A3 | Hungary | A3 | |
| RU2351339C2 | Russian Federation | C2 | |
| US7615545B2 | United States of America | B2 | |
| CN100581550C | China | C | |
| CA2468748C | Canada | C | |
| CN101757628A | China | A | |
| JP2010180236A | Japan | A | |
| US2010298279A1 | United States of America | A1 | |
| US7858605B2 | United States of America | B2 | |
| EP2305229A1 | European Patent Office (EPO) | A1 | |
| EP2305230A1 | European Patent Office (EPO) | A1 | |
| AU2008237614B2 | Australia | B2 | |
| NZ570295A | New Zealand | A | |
| IL207561A0 | Israel | A0 | |
| IL207561D0 | Israel | D0 | |
| IL162182A | Israel | A | |
| HK1154485A | Hong Kong, China | A | |
| HK1154485A1 | Hong Kong, China | A1 | |
| JP2012107052A | Japan | A | |
| NZ591627A | New Zealand | A | |
| US2012322777A1 | United States of America | A1 | |
| US8338396B2 | United States of America | B2 | |
| PL213122B1 | Poland | B1 | |
| CA2655959C | Canada | C | |
| EP1453521B1 | European Patent Office (EPO) | B1 | |
| DK1453521T3 | Denmark | T3 | |
| PT1453521E | Portugal | E | |
| ES2428118T3 | Spain | T3 | |
| SI1453521T1 | Slovenia | T1 | |
| US8680084B2 | United States of America | B2 | |
| FR15C0050I1 | France | I1 | |
| EP2305230B1 | European Patent Office (EPO) | B1 | |
| ES2561491T3 | Spain | T3 | |
| CY1114421T1 | Cyprus | T1 | |
| LU93156I2This record | Luxembourg | I2 | |
| HU230759B1 | Hungary | B1 | |
| FR15C0050I2 | France | I2 | |
| HUS1800033I1 | Hungary | I1 | |
| BRPI0214716B1 | Brazil | B1 | |
| BRPI0214716B8 | Brazil | B8 |
Numbers
- Publication, DOCDB
- 93156
- Publication, EPODOC
- LU93156I
- Application
- 93156
- Application, DOCDB
- 93156
- Application, EPODOC
- LU20160093156C
Titles2
- English
- OREUX CONTRACEPTIVES TO AVOID PREGNANCIES AND REDUCE PREMENSTRUAL SYMPTOMATOLOGY
- French
- CONTRACEPTIFS OREUX POUR EVITER LES GROSSESSES ET DIMINUER LA SYMPTOMATOLOGIE PREMENSTRUELLE
Classification
- CPC, 13
- A61K45/06
- A61K31/138
- A61K31/56
- A61K31/565
- A61K31/567
- A61K31/57
- A61P15/00
- A61P15/18
- A61P25/00
- A61P25/24
- A61P43/00
- A61P5/30
- A61P5/34
- IPC, 8
- A61K31 138
- A61K31 565
- A61K31 567
- A61K31 57
- A61K45 06
- A61P15 00
- A61P15 18
- A61P25 24